INVESTIGATIONAL DRUG PRODUCTS: REGULATORY CHANGES THAT MAY HAVE IMPLICATIONS FOR YOUR CLINICAL TRIAL CONDUCT SITES
Navigating compliance requirements in a space co-regulated at both the federal and state level can be complex and challenging. Recent changes in how the Virginia Board of Pharmacy classifies investigational… Read more »
